NCT00001383View on ClinicalTrials.gov

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 1994

Study Completion Date

January 31, 2001

Conditions
Breast CancerCancerCarcinoma, Renal CellLymphomaOvarian Cancer
Interventions
DRUG

PSC 833

DRUG

paclitaxel

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001383 - A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 | Biotech Hunter | Biotech Hunter